ADL
GILD icon

Asset Dedication LLC’s Gilead Sciences GILD Stock Holding History

Asset Dedication LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Sell
12,515
-916
-7% -$128K 0.12% 111
2025
Q4 		$1.65M Sell
13,431
-2,277
-14% -$277K 0.11% 116
2025
Q3 		$1.74M Buy
15,708
+2,188
+16% +$249K 0.12% 110
2025
Q2 		$1.5M Buy
13,520
+882
+7% +$93.9K 0.11% 116
2025
Q1 		$1.42M Buy
12,638
+6,217
+97% +$641K 0.11% 112
2024
Q4 		$593K Buy
6,421
+1,940
+43% +$175K 0.05% 195
2024
Q3 		$376K Buy
4,481
+314
+8% +$24K 0.03% 261
2024
Q2 		$286K Sell
4,167
-1,710
-29% -$114K 0.02% 281
2024
Q1 		$432K Sell
5,877
-877
-13% -$67.4K 0.03% 233
2023
Q4 		$545K Buy
6,754
+813
+14% +$63.3K 0.04% 223
2023
Q3 		$450K Sell
5,941
-73
-1% -$5.62K 0.04% 233
2023
Q2 		$464K Buy
6,014
+284
+5% +$22.6K 0.04% 233
2023
Q1 		$470K Buy
5,730
+296
+5% +$24.5K 0.04% 230
2022
Q4 		$465K Buy
5,434
+579
+12% +$45.9K 0.05% 229
2022
Q3 		$301K Buy
+4,855
New +$306K 0.03% 246
2022
Q2 		– Sell
-2,683
Closed -$160K – 666
2022
Q1 		$160K Sell
2,683
-5,323
-66% -$340K 0.02% 311
2021
Q4 		$581K Sell
8,006
-590
-7% -$40.6K 0.07% 184
2021
Q3 		$599K Buy
8,596
+1,527
+22% +$107K 0.08% 173
2021
Q2 		$486K Buy
7,069
+3,865
+121% +$258K 0.07% 187
2021
Q1 		$205K Buy
3,204
+210
+7% +$13.5K 0.05% 215
2020
Q4 		$175K Buy
2,994
+796
+36% +$48K 0.03% 249
2020
Q3 		$139K Sell
2,198
-6,277
-74% -$435K 0.03% 255
2020
Q2 		$652K Buy
8,475
+1,103
+15% +$84.5K 0.18% 122
2020
Q1 		$553K Buy
7,372
+1,391
+23% +$96.1K 0.16% 124
2019
Q4 		$389K Sell
5,981
-2,539
-30% -$165K 0.11% 145
2019
Q3 		$541K Buy
8,520
+289
+4% +$18.9K 0.18% 110
2019
Q2 		$552K Buy
8,231
+1,394
+20% +$91.7K 0.18% 111
2019
Q1 		$440K Buy
6,837
+373
+6% +$24.8K 0.15% 118
2018
Q4 		$405K Sell
6,464
-606
-9% -$42.4K 0.17% 117
2018
Q3 		$538K Buy
7,070
+440
+7% +$33.2K 0.2% 111
2018
Q2 		$476K Buy
6,630
+81
+1% +$5.72K 0.16% 119
2018
Q1 		$490K Buy
6,549
+801
+14% +$63.7K 0.24% 90
2017
Q4 		$416K Buy
5,748
+3,721
+184% +$283K 0.17% 114
2017
Q3 		$163K Sell
2,027
-327
-14% -$25K 0.08% 137
2017
Q2 		$168K Sell
2,354
-1,140
-33% -$75.9K 0.08% 141
2017
Q1 		$239K Sell
3,494
-132
-4% -$9.28K 0.13% 124
2016
Q4 		$263K Sell
3,626
-2,706
-43% -$201K 0.15% 117
2016
Q3 		$514K Sell
6,332
-158
-2% -$12.8K 0.32% 93
2016
Q2 		$552K Sell
6,490
-576
-8% -$51.1K 0.38% 79
2016
Q1 		$649K Buy
7,066
+241
+4% +$21.7K 0.48% 67
2015
Q4 		$691K Buy
+6,825
New +$710K 0.45% 70

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Asset Dedication LLC's GILD Position: Q1 2026 in Review

Asset Dedication LLC reduced its Gilead Sciences (GILD) stake by 6.8% in Q1 2026, selling an estimated $128K and leaving 12,515 shares worth $1.74M. The position accounts for 0.12% of the portfolio, ranked #111.

Asset Dedication LLC first reported a position in GILD in Q4 2015 and has held it in 41 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Asset Dedication LLC held 12,515 shares of Gilead Sciences worth $1.74M as of Q1 2026.
  • Asset Dedication LLC sold 916 Gilead Sciences shares in Q1 2026, an estimated $128K.
  • Gilead Sciences made up 0.12% of Asset Dedication LLC's portfolio in Q1 2026, its #111 holding.
  • Asset Dedication LLC first reported a position in Gilead Sciences in Q4 2015 and has held it in 41 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.